Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.840
-0.090 (-3.07%)
Aug 25, 2026, 2:15 PM EDT - Market open

Fortress Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
95114565571249
Market Cap Growth
40.32%103.22%2.43%-23.29%-71.44%-17.12%
Enterprise Value
-49105352628219
Last Close Price
2.933.662.023.019.8237.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
3.660.610.61---
PS Ratio
1.431.800.970.650.943.62
PB Ratio
0.591.83-34.0034.391.421.10
P/TBV Ratio
0.705.10-24.214.902.59

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-1.660.600.310.373.18

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.261.08-46.2055.822.590.33
Net Debt / Equity Ratio
-0.69-0.20-11.374.83-0.98-1.02
Net Debt / EBITDA Ratio
5.830.19-0.18-0.060.251.33
Net Debt / FCF Ratio
-1.140.19-0.23-0.060.271.91
Asset Turnover
0.290.380.370.370.220.19
Inventory Turnover
2.362.736.3110.5913.7928.57
Quick Ratio
3.762.200.951.131.623.26
Current Ratio
3.962.491.271.381.803.43
Return on Equity (ROE)
115.98%-108.74%--597.36%-155.06%-77.95%
Return on Assets (ROA)
-7.65%-26.62%-42.78%-36.83%-36.84%-30.65%
Return on Capital Employed (ROCE)
-11.50%-51.70%-146.50%-164.70%-122.20%-60.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
105.78%6.00%-82.28%-111.11%-121.69%-25.98%
FCF Yield
128.78%-57.90%-143.45%-235.07%-255.99%-48.62%
Buyback Yield / Dilution
-25.98%-34.24%-156.25%-36.89%-8.78%-13.46%
SEC Filings: 10-K · 10-Q